As of 2024-12-12, the Relative Valuation of Advanced Oncotherapy PLC (AVO.L) is (131.44) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 1.93 GBP, the upside of Advanced Oncotherapy PLC based on Relative Valuation is -6928.2%.
The range of the Relative Valuation is (128.03) - (143.19) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 18.9x | 18.5x |
| Forward P/E multiples | 15.1x - 20.4x | 16.2x |
| Fair Price | (128.03) - (143.19) | (131.44) |
| Upside | -6751.1% - -7538.3% | -6928.2% |
| Date | P/E |